It is time to reconsider antibodies against integrin β4 in mucous membrane pemphigoid: Comment on ‘Native collagen XVII complex ELISA: An approach for diagnosis and monitoring of anti‐integrin β4 mucous membrane pemphigoid’
- 28 June 2024
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (2) , e198-e199
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Native collagen XVII complex ELISA: An approach for diagnosis and monitoring of anti‐integrin β4 mucous membrane pemphigoidJournal of the European Academy of Dermatology and Venereology, 2023
- Native Autoantigen Complex Detects Pemphigoid AutoantibodiesJID Innovations, 2023
- Anti‐β4 integrin autoantibodies in patients with mucous membrane pemphigoid: A retrospective analysis from a tertiary centre in ItalyJournal of the European Academy of Dermatology and Venereology, 2022
- European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part IIJournal of the European Academy of Dermatology and Venereology, 2021
- Integrin ß4 is a major target antigen in pure ocular mucous membrane pemphigoidEuropean Journal Of Dermatology, 2016
- The Autoantibodies to α6β4 Integrin of Patients Affected by Ocular Cicatricial Pemphigoid Recognize Predominantly Epitopes Within the Large Cytoplasmic Domain of Human β4The Journal of Immunology, 2000
- Influence of intravenous immunoglobulin therapy on serum levels of anti-ß4 antibodies in ocular cicatricial pemphigoid: A correlation with disease activityCurrent Eye Research, 2000